Rhenman & Partners Asset Management AB - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 152 filers reported holding LOXO ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.7%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2018$1,401,000
-83.6%
10,000
-80.0%
0.16%
-81.3%
Q3 2018$8,542,000
-60.0%
50,000
-59.3%
0.86%
-60.8%
Q2 2018$21,331,000
+146.5%
122,961
+63.9%
2.18%
+104.6%
Q1 2018$8,653,000
+13.9%
75,000
-16.9%
1.07%
+3.9%
Q4 2017$7,600,000
+10.0%
90,280
+20.4%
1.03%
+16.4%
Q3 2017$6,909,00075,0000.88%
Other shareholders
LOXO ONCOLOGY INC shareholders Q3 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 3,438,920$289,488,00057.19%
DAFNA Capital Management LLC 296,000$24,917,00013.42%
Casdin Capital, LLC 360,000$30,305,0007.38%
Opaleye Management Inc. 176,300$14,841,0004.75%
DRIEHAUS CAPITAL MANAGEMENT LLC 574,495$48,361,0001.84%
SECTORAL ASSET MANAGEMENT INC 152,185$12,811,0001.60%
AWM Investment Company, Inc. 85,000$7,155,0001.39%
Eventide Asset Management 285,000$23,991,0001.25%
Rock Springs Capital Management LP 310,000$26,096,0001.18%
Crawford Lake Capital Management, LLC 53,420$4,497,0001.06%
View complete list of LOXO ONCOLOGY INC shareholders